United Therapeutics Corporation (UTHR)
Return on assets (ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 1,195,100 | 984,800 | 727,300 | 475,800 | 514,800 |
| Total assets | US$ in thousands | 7,364,000 | 7,167,000 | 6,044,500 | 5,169,100 | 4,615,000 |
| ROA | 16.23% | 13.74% | 12.03% | 9.20% | 11.15% |
December 31, 2024 calculation
ROA = Net income ÷ Total assets
= $1,195,100K ÷ $7,364,000K
= 16.23%
The return on assets (ROA) for United Therapeutics Corporation has shown a fluctuating trend over the past five years, as follows:
- As of December 31, 2020, the ROA stood at 11.15%, indicating that the company generated $0.1115 in net income for every dollar of assets owned.
- By December 31, 2021, the ROA had decreased to 9.20%, reflecting a decline in the company's effectiveness in utilizing its assets to generate profits.
- However, in the following years, the ROA exhibited a positive upturn. It increased to 12.03% as of December 31, 2022, further rising to 13.74% by December 31, 2023.
- The most recent data point, as of December 31, 2024, shows a significant improvement in the ROA to 16.23%, indicating that United Therapeutics Corporation has been more efficient in leveraging its assets to generate higher returns.
Overall, the ROA trend suggests that the company's asset utilization and profitability have shown variability but have strengthened in recent years, indicating potential improvements in operational efficiency and financial performance.
Peer comparison
Dec 31, 2024